Metastases In The Liver Doctors Abroad — Page 3

Associate Professor Tahsin Ozatli is a specialist oncologist at Istinye University Liv Hospital who focuses on gastrointestinal cancers and secondary liver tumours.

• Specialises in managing metastases from primary lung, breast, and bowel sites
• Holds academic rank of Associate Professor – a title awarded for clinical and research excellence
• Extensive background at the Ankara Oncology Clinic – a major Turkish centre for cancer treatment
• Trained at the Erzurum Regional Training and Research Hospital in complex oncology care
• Expertise in systemic therapies for patients with liver involvement

Professor Muzaffer Al completed advanced training in oncological surgery at Istanbul University Cerrahpaşa – one of the region's most reputable medical institutions for complex cancer care.

• Specialises in laparoscopic cancer surgery – uses small incisions to remove tumours for less scarring and quicker recovery
• Performs minimally invasive surgery for various abdominal cancers and liver involvement
• Trained in laparoscopic antireflux procedures at Istanbul University Çapa
• Leads clinical teams at Büyük Anadolu Hospitals in Samsun

Professor Gul Alco is a leading radiation oncologist at Medipol Hospital who specialises in using high-precision radiotherapy to treat liver metastases.

• Uses Stereotactic Body Radiotherapy (SBRT) to target liver tumours with extreme precision while sparing healthy tissue
• Professor at Istanbul Medipol University – one of Turkey's premier medical training institutions
• Specialises in managing complex secondary cancers that have spread from other organs
• Focuses on non-surgical interventions that offer faster recovery times for patients
• Member of the Turkish Society for Radiation Oncology

Professor Alemdar is a specialist medical oncologist at Medical Park Antalya who focuses on managing complex secondary liver tumours.

• Specialised in medical oncology at Akdeniz University – a major Turkish clinical centre
• Focuses on systemic therapies to shrink tumours before or after surgical intervention
• Expert in internal medicine for monitoring patient health during intensive treatment
• Coordinates multi-stage care for patients with cancer that has spread locally
• Practices at a JCI-accredited hospital complex for high standards of patient safety

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist who specialises in managing secondary liver tumours using the latest systemic therapies.

• Directs treatment at Medipol Bahçelievler University Hospital using targeted and immune-based protocols
• Expert in Peptide Receptor Radionuclide Therapy (PRRT) – uses radioactive molecules to target and destroy neuroendocrine metastases
• Active sub-investigator in international clinical trials for emerging cancer drugs with Roche, Pfizer, and Bayer
• ESMO Board Certified – meets the highest European professional standards for cancer care

Dr Volkan Kinas is an oncological surgeon at Büyük Anadolu Hospital specialising in complex abdominal and digestive tract tumours.

• Focuses on surgical removal of liver metastases from colon and gastric cancers
• Performs pancreatic and bile duct surgery to manage secondary liver spread
• Uses oncological resection techniques to remove tumours from the liver and gallbladder
• Specialises in gastrointestinal oncology, including treatment for metastatic gastric and colon cancers

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.